KMS Medisurgi Ltd
KMS Medisurgi Ltd (KMSMEDI) last reported results for the quarter ended Mar 2026, with sales of ₹5.59 crore and net profit of ₹0.01 crore. The stock last traded at ₹133, a market capitalisation of ₹43.8 crore, on a P/E of 175. Over the past 52 weeks the stock has ranged between ₹126 and ₹133. Figures are as of 6 Oct 2026 and are not real time.
KMS Medisurgi Ltd share price and key metrics
- Current price
- ₹133
- Market cap
- ₹43.8 cr
- Stock P/E
- 175
- Book value
- ₹25.2
- ROE
- 3.05%
- ROCE
- 5.20%
- Dividend yield
- 0.04%
- 52w high / low
- 133/126
Metrics as of 6 Oct 2026. Not real time.
Track KMS Medisurgi Ltd
Cruxal reads every KMS Medisurgi Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
KMS Medisurgi Ltd growth and returns
- 10 Years
- 4%
- 5 Years
- 10%
- 3 Years
- 3%
- TTM
- -12%
- 10 Years
- 6%
- 5 Years
- 16%
- 3 Years
- -24%
- TTM
- -43%
- 10 Years
- %
- 5 Years
- 31%
- 3 Years
- 13%
- 1 Year
- 5%
- 10 Years
- 4%
- 5 Years
- 5%
- 3 Years
- 5%
- Last Year
- 3%
KMS Medisurgi Ltd quarterly results
In the quarter ended Mar 2026, sales were ₹5.59 cr, down 8.7% from ₹6.12 cr a year earlier. Net profit was ₹0.01 cr, down 97.2% year on year.
| ₹ crore | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 5.68 | 5.35 | 7.15 | 6.73 | 7.81 | 6.12 | 6.62 | 5.59 |
| Expenses | 5.34 | 4.72 | 6.24 | 6.85 | 7.59 | 5.4 | 6.11 | 5.2 |
| Operating profit | 0.34 | 0.63 | 0.91 | -0.12 | 0.22 | 0.72 | 0.51 | 0.39 |
| OPM % | 5.99% | 11.78% | 12.73% | -1.78% | 2.82% | 11.76% | 7.70% | 6.98% |
| Other income | 0 | 0.01 | 0.06 | 0.03 | 0.02 | 0.01 | 0.04 | -0.03 |
| Interest | 0 | 0 | 0 | 0.02 | 0.01 | 0.08 | 0.06 | 0.05 |
| Depreciation | 0.12 | 0.19 | 0.12 | 0.13 | 0.12 | 0.14 | 0.19 | 0.28 |
| Profit before tax | 0.22 | 0.45 | 0.85 | -0.24 | 0.11 | 0.51 | 0.3 | 0.03 |
| Tax % | -18.18% | 28.89% | 28.24% | -37.50% | 27.27% | 27.45% | 20.00% | 66.67% |
| Net profit | 0.26 | 0.31 | 0.6 | -0.15 | 0.08 | 0.36 | 0.23 | 0.01 |
| EPS (₹) | 0.79 | 0.94 | 1.82 | -0.45 | 0.24 | 1.09 | 0.70 | 0.03 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
KMS Medisurgi Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.9 | 7.32 | 9.86 | 10.34 | 7.51 | 10.32 | 11.03 | 13.88 | 13.94 | 12.21 |
| Operating profit | 0.95 | 0.47 | 0.3 | 0.66 | 0.5 | 0.53 | 0.96 | 0.85 | 0.95 | 0.93 |
| OPM % | 12.03% | 6.42% | 3.04% | 6.38% | 6.66% | 5.14% | 8.70% | 6.12% | 6.81% | 7.62% |
| Net profit | 0.21 | 0.1 | 0.12 | 0.11 | 0.12 | 0.22 | 0.57 | 0.45 | 0.44 | 0.25 |
| EPS (₹) | 0.88 | 0.30 | 0.36 | 0.33 | 0.36 | 0.67 | 1.73 | 1.36 | 1.33 | 0.76 |
TTM is the trailing twelve months to the most recent quarter.
KMS Medisurgi Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 2.40 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 |
| Reserves | 1.12 | 2.85 | 2.95 | 3.05 | 3.15 | 3.37 | 3.93 | 4.36 | 4.79 | 5.01 |
| Borrowings | 2.73 | 1.91 | 1.13 | 1.11 | 1.03 | 0.99 | 0.99 | 0.54 | 0.91 | 0.77 |
| Other liabilities | 2.36 | 2.14 | 3.15 | 1.64 | 1.86 | 2.17 | 1.51 | 2.65 | 1.34 | 1.47 |
| Total liabilities | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 10.55 |
| Fixed assets | 2.69 | 2.25 | 2.20 | 1.81 | 1.65 | 1.48 | 1.82 | 1.65 | 1.68 | 2.93 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 5.92 | 7.95 | 8.33 | 7.29 | 7.69 | 8.35 | 7.91 | 9.20 | 8.66 | 7.62 |
| Total assets | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 10.55 |
As reported by the company. Total assets equal total liabilities by construction.
KMS Medisurgi Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0.90 | -1.57 | 0.75 | -0.84 | 0.53 | -0.07 | 0.46 | 1.21 | 0.74 | 1.51 |
| Cash from investing | -1.10 | 0.11 | -0.31 | 0.01 | -0.10 | -0.12 | -0.66 | -0.51 | -0.96 | -0.61 |
| Cash from financing | 1.75 | 1.57 | -0.81 | -0.06 | -0.11 | -0.02 | -0.01 | -0.47 | 0.27 | -0.26 |
| Net cash flow | 1.56 | 0.10 | -0.37 | -0.88 | 0.32 | -0.21 | -0.21 | 0.23 | 0.05 | 0.64 |
| Free cash flow | -0.29 | -1.58 | 0.36 | -0.86 | 0.36 | -0.19 | -0.20 | 1.09 | 0.44 | -0.21 |
| CFO / operating profit | 106% | -309% | 250% | -129% | 108% | 0% | 59% | 173% | 96% | 171% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
KMS Medisurgi Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 10.76% | 5.17% | 3.76% | 3.37% | 3.61% | 3.83% | 8.31% | 8.40% | 8.26% | 5.20% |
| Debtor days | 185.73 | 233.36 | 186.94 | 194.15 | 305.22 | 231.31 | 216.42 | 152.00 | 111.02 | 96.26 |
| Inventory days | 6.24 | 85.34 | 82.27 | 62.14 | — | 45.45 | 42.45 | 70.96 | 87.18 | 105.11 |
| Days payable | 139.76 | 134.58 | 134.09 | 70.42 | — | 100.27 | 58.60 | 85.22 | 41.17 | 52.14 |
| Cash conversion cycle | 52.21 | 184.13 | 135.12 | 185.86 | 305.22 | 176.49 | 200.27 | 137.74 | 157.03 | 149.23 |
| Working capital days | 9.24 | 158.07 | 148.07 | 188.85 | 253.22 | 200.54 | 199.54 | 153.84 | 144.01 | 142.59 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
KMS Medisurgi Ltd shareholding pattern
Promoters held 74.42% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.42% | 74.42% | 74.42% | 74.42% | 74.42% | 74.42% | 74.42% | 74.42% |
| Public | 25.58% | 25.58% | 25.58% | 25.57% | 25.57% | 25.57% | 25.57% | 25.57% |
| No. of shareholders | 59 | 59 | 59 | 67 | 64 | 64 | 64 | 63 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
KMS Medisurgi Ltd corporate filings
- KMS Medisurgi Limited announces cessation of Independent Director Mr. Hardik Rajnikant Bhatt effective September 30, 2026, with no immediate financial or operational disclosures.Company Updatelow impact
Cruxal's analysis: KMS Medisurgi Limited has formally disclosed the end of Mr. Hardik Rajnikant Bhatt's…
Read the full analysis - KMS Medisurgi Limited announces cessation of Independent Director Mr. Kamlesh Rajani Chunilal after completing his second term on September 30, 2026Company Updatelow impact
Cruxal's analysis: KMS Medisurgi Limited has formally disclosed the end of Mr. Kamlesh Rajani Chunilal's…
Read the full analysis - KMS Medisurgi Limited's AGM Voting Results Confirm Strong Shareholder Support for Financial and Board ResolutionsAGM/EGMlow impact
Cruxal's analysis: KMS Medisurgi Limited reported full voting support (100%) for key resolutions including…
Read the full analysis - KMS Medisurgi Limited holds 28th AGM; no new financial disclosures or strategic updates providedAGM/EGMlow impact
Cruxal's analysis: KMS Medisurgi Limited conducted its 28th Annual General Meeting on September 30, 2026…
Read the full analysis - Intimation of closure of trading window under ther SEBI (Prohibition of Insider trading) Regulation, 2015.Insider Trading / SASTlow impact
- KMS Medisurgi Ltd submits Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: KMS Medisurgi Limited has filed its Annual Report for the financial year 2025-26 in…
Read the full analysis - KMS Medisurgi Limited announces dividend of 5 paise per share for FY2026Company Updatelow impact
Cruxal's analysis: KMS Medisurgi Limited has declared a dividend of 5 paise (0.5%) per equity share for the…
Read the full analysis - KMS Medisurgi Limited Announces 28th Annual General Meeting and Declares Final Dividend of 0.05 INR per ShareAGM/EGMlow impact
Cruxal's analysis: KMS Medisurgi Limited has issued a formal notice for its 28th Annual General Meeting…
Read the full analysis - KMS Medisurgi Limited announces 28th AGM and recommends final dividend of INR 0.05 per share for FY 2025-26Board Meetinglow impact
Cruxal's analysis: KMS Medisurgi Limited has scheduled its 28th Annual General Meeting for September 30…
Read the full analysis - KMS Medisurgi Limited schedules Board Meeting for September 5, 2026, to approve FY26 financials and consider final dividendBoard Meetinglow impact
Cruxal's analysis: KMS Medisurgi Limited has announced a board meeting scheduled for September 5, 2026…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.